The FDA announced new provisions that require sponsors to submit Diversity Action Plans. But what does that mean for the ...
Increasingly advanced therapies are making their way into the pharmaceutical mainstream – but so too are an increasingly ...
Palleos Healthcare has a distinguished history of advancing medical innovations, leveraging its extensive experience and network to accelerate the development of new therapies. By integrating academic ...
The FDA mandate to increase diversity in clinical trials fails to address critical issues in treatment for Black women, according to experts.
Clinical research is a field of paramount importance in the realm of healthcare and pharmaceuticals. It is the driving force ...
The Punch Newspapers on MSN9d
From Patient to Partner: The Importance of Joining Breast Cancer Clinical TrialsDreams are often born through the experiences that challenge and shape us, evolving from moments of personal impact into a ...
GlobalData on MSN5mon
Flexibility of alternative trial designs crucial for cell and gene therapy researchOn Clinical Trials Day, we take a look at how sponsors are exploring alternative designs to study cell and gene therapies.
Immunotherapy and precision medicine show promise in better fighting cancer. What else does the research tell us?
DelveInsight's 'JAK Inhibitors Pipeline Insight 2024' report provides comprehensive global coverage of pipeline JAK ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback